Picard Medical is trading 10.90% higher at $4.28, supported primarily by healthcare-sector strength as XLV gains 1.37%.
- The stock rebounded after the exceptionally volatile September 1 session, when it closed at $3.86, down 54.37%.
- No fresh company-specific announcement was identified on September 2, 2026; a broader rebound in U.S. equities also supported the move.
- Earlier second-quarter revenue growth and improved profitability remain background context, not a new catalyst.